Watch the webinar on ASH 2019 highlights held yesterday by Myeloma Patients Europe (MPE)AL amyloidosis, Conferences, MPE, Myeloma, Videos15 January 2020
MPE webinar on ASH 2019 myeloma and AL amyloidosis highlightsAL amyloidosis, Conferences, MPE, Myeloma20 December 2019
New data show HARMONY Alliance’s big data platform can improve the prognostic tool for myeloma patientsMPE, Myeloma6 December 2019
The European Medicines Agency (EMA) recommends extension of indications for daratumumabAccess, Myeloma21 October 2019
European Commission approves elotuzumab plus pomalidomide and dexamethasone for relapsed and refractory myelomaAccess, Myeloma28 August 2019
Janssen seeks European marketing authorisation for subcutaneous (under the skin) daratumumab (Darzalex®)Access, Myeloma19 July 2019
HARMONY reaches milestone capturing data from 45,000 patients with blood cancersMPE, Myeloma25 June 2019
